APA strongly supports the U.S. Food and Drug Administration’s proposed reclassification of electroco...

Twice-weekly high-dose unilateral electroconvulsive therapy (ECT) appears to be no less effective th...

Five years after it last broached the matter, the Food and Drug Administration (FDA) is again propos...

Yesterday, the Food and Drug Administration announced that it is making changes to the requirements ...

Yesterday, the Food and Drug Administration approved Addyi (flibanserin) to treat acquired, generali...

APA today expressed support for the 21st Century Cures Act (HR 6), scheduled for a vote tomorrow in ...